Generex Biotechnology Corp (GNBT) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
10102 USA TODAY WAY MIRAMAR, FL 33025 |
| State of Incorp. | DE |
| Fiscal Year End | July 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 4/30/2021 MRQ | 7/31/2020 | 7/31/2019 | 7/31/2018 | 7/31/2017 | 7/31/2016 | 7/31/2015 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 15 | 298 | 1,046 | 2,879 | 17 | 750 | |||
| Cash and cash equivalents | 15 | 298 | 1,046 | 2,879 | 17 | 750 | |||
| Inventory, net of allowances, customer advances and progress billings | 742 | 363 | 12 | 10 | |||||
| Inventory | 742 | 363 | 12 | 10 | |||||
| Intangible current assets | 108 | ||||||||
| Other current assets | 332 | 276 | 96 | 22 | 8 | 51 | |||
| Other undisclosed current assets | 165 | 36 | 34 | (108) | |||||
| Total current assets: | 1,255 | 974 | 1,188 | 2,911 | 25 | 801 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 38 | ✕ | ✕ | ✕ | ✕ | ||||
| Property, plant and equipment | 214 | 500 | 32 | 1 | 1 | 3 | |||
| Intangible assets, net (including goodwill) | 37,552 | 39,381 | 3,188 | 2,911 | 1,430 | ||||
| Goodwill | 34,489 | 38,298 | |||||||
| Intangible assets, net (excluding goodwill) | 3,063 | 1,083 | 3,188 | 2,911 | 1,430 | ||||
| Other undisclosed noncurrent assets | 6,324 | 8,782 | 2,199 | 4,272 | |||||
| Total noncurrent assets: | 44,128 | 48,662 | 5,419 | 7,183 | 1 | 1,433 | |||
| TOTAL ASSETS: | 45,383 | 49,636 | 6,607 | 10,095 | 26 | 2,234 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 23,908 | 19,056 | 11,045 | 10,173 | 8,951 | 8,019 | |||
| Interest and dividends payable | 3,911 | ||||||||
| Employee-related liabilities | 312 | 357 | |||||||
| Accounts payable | 1,316 | 3,751 | 3,157 | ||||||
| Accrued liabilities | 326 | 326 | |||||||
| Other undisclosed accounts payable and accrued liabilities | 18,681 | 19,056 | 11,045 | 10,173 | 4,562 | 4,178 | |||
| Debt | 11,166 | ||||||||
| Derivative instruments and hedges, liabilities | 1,317 | ||||||||
| Other undisclosed current liabilities | 4,981 | 9,890 | 14,184 | 13,738 | 50 | ||||
| Total current liabilities: | 41,371 | 28,946 | 25,229 | 23,911 | 9,001 | 8,019 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 500 | ||||||||
| Long-term debt, excluding current maturities | 500 | ||||||||
| Liabilities, other than long-term debt | 1,317 | 7,820 | 2,049 | 2,363 | |||||
| Derivative instruments and hedges, liabilities | 1,317 | 7,820 | 2,049 | 2,363 | |||||
| Other undisclosed noncurrent liabilities | 10,079 | (7,035) | 24,963 | 66,060 | 193 | 142 | |||
| Total noncurrent liabilities: | 11,896 | 785 | 24,963 | 66,060 | 2,242 | 2,506 | |||
| Other undisclosed liabilities | 8,158 | ||||||||
| Total liabilities: | 53,267 | 37,889 | 50,192 | 89,971 | 11,243 | 10,524 | |||
| Temporary equity, carrying amount | 4,074 | 4,074 | |||||||
| Equity | |||||||||
| Equity, attributable to parent, including: | (11,958) | 7,673 | (43,585) | (79,876) | (11,217) | (8,290) | |||
| Common stock | 82 | 62 | 1 | 1 | 909 | 825 | |||
| Additional paid in capital | 429,744 | 408,567 | 368,410 | 368,410 | 362,780 | 362,557 | |||
| Accumulated other comprehensive income | 780 | 797 | 798 | 783 | 799 | 809 | |||
| Accumulated deficit | (452,063) | (418,728) | (375,704) | (372,481) | |||||
| Warrants and rights outstanding | 2,363 | ||||||||
| Other undisclosed equity, attributable to parent | 9,498 | 16,974 | (412,794) | (449,070) | (2,363) | ||||
| Total equity: | (11,958) | 7,673 | (43,585) | (79,876) | (11,217) | (8,290) | |||
| TOTAL LIABILITIES AND EQUITY: | 45,383 | 49,636 | 6,607 | 10,095 | 26 | 2,234 | |||
Income Statement (P&L) ($ in thousands)
| 4/30/2021 TTM | 7/31/2020 | 7/31/2019 | 7/31/2018 | 7/31/2017 | 7/31/2016 | 7/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 6,204 | 703 | ||||||
| Cost of revenue | (580) | (4,138) | ||||||
| Cost of goods and services sold | (645) | |||||||
| Other undisclosed gross profit | 2,661 | |||||||
| Gross profit: | 2,082 | 2,065 | 703 | |||||
| Operating expenses | (20,019) | (26,411) | (3,199) | (1,597) | (1,903) | (3,883) | ||
| Operating loss: | (17,937) | (24,345) | (2,496) | (1,597) | (1,903) | (3,883) | ||
| Nonoperating income (Investment Income, Nonoperating) | 700 | 0 | ||||||
| Interest and debt expense | (7,104) | (7,104) | (584) | (743) | (419) | (22) | ||
| Loss from continuing operations: | (25,041) | (31,449) | (2,379) | (2,340) | (2,321) | (3,905) | ||
| Loss before gain (loss) on sale of properties: | ✕ | (25,041) | (31,449) | (2,379) | (2,340) | (2,321) | (3,905) | |
| Other undisclosed net income | 1,712 | |||||||
| Net loss: | (25,041) | (31,449) | (2,379) | (2,340) | (2,321) | (2,193) | ||
| Net income attributable to noncontrolling interest | 897 | 1,665 | 385 | 6,816 | ||||
| Other undisclosed net income (loss) attributable to parent | (10,088) | 18,777 | 37,943 | (81,309) | (902) | |||
| Net income (loss) attributable to parent: | (34,232) | (11,007) | 35,949 | (76,833) | (3,223) | (2,193) | ||
| Preferred stock dividends and other adjustments | (340) | |||||||
| Other undisclosed net income available to common stockholders, basic | 897 | 1,665 | 385 | 6,816 | ||||
| Net income (loss) available to common stockholders, diluted: | (33,335) | (9,341) | 36,334 | (70,016) | (3,223) | (2,533) | ||
Comprehensive Income ($ in thousands)
| 4/30/2021 TTM | 7/31/2020 | 7/31/2019 | 7/31/2018 | 7/31/2017 | 7/31/2016 | 7/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (25,041) | (31,449) | (2,379) | (2,340) | (2,321) | (2,193) | ||
| Comprehensive loss: | (25,041) | (31,449) | (2,379) | (2,340) | (2,321) | (2,193) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 897 | 1,665 | 385 | 6,816 | ||||
| Other undisclosed comprehensive income, net of tax, attributable to parent | 37 | |||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (24,144) | (29,784) | (1,994) | 4,476 | (2,321) | (2,157) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.